American Academy Of Otolaryngic Allergy

92
American Academy Of Otolaryngic Allergy
American Academy Of Otolaryngic Allergy is listed in the Ear, Nose & Throat Doctors category in Washington, District of Columbia. Displayed below are the social networks for American Academy Of Otolaryngic Allergy which include a Facebook page, a Linkedin company page and a Twitter account. The activity and popularity of American Academy Of Otolaryngic Allergy on these social networks gives it a ZapScore of 92.

Contact information for American Academy Of Otolaryngic Allergy is:
1990 M St NW
Washington, DC 20036
(202) 955-5010
Do you own or manage this business? Click here to claim the American Academy Of Otolaryngic Allergy listing and add social networks, logos, descriptions and more.

American Academy Of Otolaryngic Allergy Contact Information:

Social Posts for American Academy Of Otolaryngic Allergy

New #IFAR podcast is out: Ergonomic analysis of the surgical position in functional endoscopic sinus surgery with Guest Vijay Ramakrishnan. Listen here: http://www.scopeitoutpodcast.com/?elq_mid=17257&elq_cid=4926907


Allergy Friendly #Easter2017 Guide twitter.com/LakeMaryENT/st…


Asthma inhalers #recall reuters.com/article/us-gsk…

Asthma inhalers #recall
GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated, the British drugmaker said on Tuesday.


FDA alerts consumers of nationwide voluntary recall of #EpiPen and EpiPen Jr fda.gov/FDAgov/NewsEve…

Nationwide voluntary recall of #EpiPen and EpiPen Jr

FDA approves new eczema drug Dupixent https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549078.htm
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisa...


FDA approves new eczema drug Dupixent fda.gov/FDAgov/NewsEve…


2017 AAOA Basic Course - Schedule Available Online #2017BasicAAOA aaoaf.org/pr.aspx?PAGE_I…

2017 AAOA Basic Course - Schedule Available Online #2017BasicAAOA http://www.aaoaf.org/pr.aspx?PAGE_ID=173